# Biomat USA, Inc. – FDA Inspection, Jun 15, 2012

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8bcc679f-7b08-405f-91df-940d75b1ce9c
Source feed: FDA_Inspections

> FDA inspection 789152 of Biomat USA, Inc., June 15, 2012. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 789152
- Company Name: Biomat USA, Inc.
- Inspection Date: 2012-06-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1177924 - 2022-08-17
- FDA Inspection 1057030 - 2018-05-30
- FDA Inspection 881284 - 2014-06-06
- FDA Inspection 677941 - 2010-06-24
- [FDA Inspection 602283 - 2009-07-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/93f69df0-ee0a-4cae-a225-a5bdbe39e954)

Company: https://www.keypedia.com/companies/biomat-usa-inc/15429a38-3ef3-4731-8426-2197cf7d5445

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d